The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Mojcik Christopher F since year 2005.
The trader's CIK number is 1231951.
At the time of this reporting, Mojcik Christopher F is the SVP Clinical Develop of Alexion Pharmaceuticals Inc .
(stock ticker symbol ALXN).
See this page for all insider trading activities at Alexion Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2007-05-29||ALXN||Alexion Pharmaceuticals Inc||Sale||10,532||47.80||503,387|
|2007-05-29||ALXN||Alexion Pharmaceuticals Inc||Option Ex||103,875||.00||0|
|2007-05-29||ALXN||Alexion Pharmaceuticals Inc||Sale||29,184||47.06||1,373,399|
|2007-05-29||ALXN||Alexion Pharmaceuticals Inc||Sale||59,136||47.26||2,794,767|
|2007-05-29||ALXN||Alexion Pharmaceuticals Inc||Buy||5,023||47.11||236,633|
|2007-03-12||ALXN||Alexion Pharmaceuticals Inc||Sale||569||37.15||21,138|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mojcik Christopher F (SVP Clinical Develop of Alexion Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.